参考文献/References:
[1] Jeyakkumar P,Zhang L,Avula SR,et al.Design,synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents[J].Eur J Med Chem,2016,122:205-215.
[2] Ye WL,Tang N,Wen YB,et al.Underlying renal insufficiency:the pivotalrisk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease[J].Int Urol Nephrol,2016,48(11):1863-1871.
[3] 吴 鹰,刘晓莉.系统性红斑狼疮患者C反应蛋白及白细胞与血脂的关系[J].实用医学杂志,214,30(7):1097-1100.
Wu Y,Liu XL.The relationship between C reactive protein and whiteblood cell and serum lipids in patients with systemic lupus erythematosus[J].The Journal of Practical Medicine,2014,30(7):1097-1100.
[4] 陈 杰,胡 娜,苏斌涛,等.系统性红斑狼疮患者血清中Tim-1蛋白水平及其基因多态性[J].中国免疫学杂志,2014,30(1):114-116,120.
Chen J,Hu N,Su BT,et al.Serum level of Tim-1 protein and genetic variations in Tim-1 gene in patients with systemic lupus erythematosus[J].Chinese Journal of Immunology,2014,30(1):114-116,120.
[5] Han K,Peyret T,Marchand M,et al.Population phar-macokinetics of bevacizumab in cancer patients with external validation[J].Cancer Chemother Pharmacol,2016,78(2):341-351.
[6] Perontsis S,Hatzidimitriou AG,Papadopoulos AN,et al.Nickel-diflunisal complexes:synthesis,characterization,in vitro antioxidant activity and interaction with DNA and albumins[J].J Inorg Biochem,2016,162:9-21.
[7] 黄中伟,陈军浩,张立平.系统性红斑狼疮患者外周血调节性B细胞的检测及意义[J].现代检验医学杂志,2014,29(2):115-116,120.
Huang ZW,Chen JH,Zhang LP.Detection of regulatory B cell in peripheral blood form patients with systemic lupus erythematosus[J].Journal of Modern Laboratory Medicine,2014,29(2):115-116,120.
[8] Colina-Vegas L,Dutra JL,Villarreal W,et al.Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes:Interaction with DNA,BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis[J].J InorgBiochem,2016,162:135-145.
[9] Naz F,Jyoti S,Akhtar N,et al.Effect of oral contraceptive pillson the blood serum enzymes and DNA damage in lymphocytes among users[J].Indian J Clin Biochem,2016,31(3):294-301.
[10] Xu Z,Liu Y,Zhou S,et al.Analysis of the interaction of Dp44mT with human serum albumin and calf thymus DNA using molecular docking and spectroscopic techniques[J].Int J Mol Sci,2016,17(7):1042.
[11] 杜文涵,王 玲,李 慧,等.系统性红斑狼疮患者血清apo M的表达及其与疾病活动度的相关性[J].中南大学学报(医学版),2015,40(4):367-372.
Du WH,Wang L,Li H,et al.Association of serum level of apolipoprotein M with disease activity in systemic lupus erythematosus[J].Journal of Central South University(Medical Science),2015,40(4):367-372.
[12] 徐庆雷,朱宝林,马小波,等.系统性红斑狼疮患者外周血CD4+T细胞来源瘦素水平及意义[J].现代检验医学杂志,2013,28(5):30-32,35.
Xu QL,Zhu BL,Ma XB,et al.Level of CD4+T cell-derived leptin inperipheral blood mononuclear cells from systemic lupus erythematosus and its significance[J].Journal of Modern Laboratory Medicine,2013,28(5):30-32,35.
[13] Roy AS,Samanta SK,Ghosh P,et al.Cell cytotoxicity and serum albumin binding capacity of the morin-Cu(ii)complex and its effect on deoxyribonucleicacid[J].Mol Biosyst,2016,12(9):2818-2833.
[14] 饶 慧,肖嫦娟,曾清华,等.来氟米特联合糖皮质激素治疗系统性红斑狼疮的临床疗效及对血清IL-8和IL-10水平的影响[J].中国老年学杂志,2015,35(23):6874-6876.
Rao H,Xiao CJ,Zeng QH,et al.Effects of leflunomide combined withglucocorticoid on systemic lupus erythematosus and the level of serum IL-8 andIL-10 in patients with systemic lupus erythematosus[J].Chinese Journal of Gerontology,2015,35(23):6874-6876.
[15] 侯秀竹,张 萌,崔丽艳.系统性红斑狼疮患者并发骨质疏松的血清免疫学相关危险因素分析[J].山东医药,2015,55(24):79-80.
Hou XZ,Zhang M,Cui LY.Analysis of serum immunological risk factors in patients with systemic lupus erythematosus complicated with osteoporosis[J].Shandong Medical Journal,2015,55(24):79-80.